Chlamydia trachomatis testing sensitivity in midstream compared with first-void urine specimens

Annals of Family Medicine

Volumn 10, Issue 1, 2012, Pages 50-53

  Mangin, Derelie ^a   Murdoch, David ^a   Wells, J Elisabeth ^a   Coughlan, Edward ^b   Bagshaw, Sue ^c   Corwin, Paul ^d   Chambers, Stephen ^a   Toop, Les ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b CANTERBURY DISTRICT HEALTH BOARD   (New Zealand)

^c Christchurch Youth Health Clinic   (New Zealand)

^d A private practice   (New Zealand)

Author keywords

Chlamydia trachomatis; Urinary tract infections

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; FEMALE; HUMAN; ISOLATION AND PURIFICATION; METHODOLOGY; MICROBIOLOGY; MIDDLE AGED; NEW ZEALAND; NUCLEIC ACID AMPLIFICATION; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; STANDARD; URINALYSIS; URINE;

ADOLESCENT; ADULT; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; FEMALE; HUMANS; MIDDLE AGED; NEW ZEALAND; NUCLEIC ACID AMPLIFICATION TECHNIQUES; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; URINE; URINE SPECIMEN COLLECTION; YOUNG ADULT;

EID: 84855732436     PISSN: 15441709     EISSN: 15441717     Source Type: Journal    
DOI: 10.1370/afm.1323     Document Type: Article

References (12)

1. Chlamydia-a testing issue. Lancet. 2005;365(9460):630.
2. Cook RL, Hutchison SL, Ostergaard L, Braithwaite RS, Ness RB. Systematic review: noninvasive testing for Chlamydia trachomatis and Neisseria gonorrhoeae. Ann Intern Med. 2005;142(11):914-25.
3. US Preventive Services Task Force. Screening for Chlamydial Infection: US Preventive Services Task Force Recommendation Statement. Rockville, MD: Agency for Healthcare Research and Quality; 2007. http://www.ahrq.gov/clinic/uspstf07/chlamydia/chlamydiars.ht.
4. Association of Public Health Laboratories. Laboratory diagnostic testing for Chlamydia trachomatis and Neisseria gonorrhoeae. Expert Consultation Meeting Summary Report; January 13-15, 2009; Atlanta, GA. Silver Spring, MD: Association of Public Health Laboratories; 2009. http://www.aphl.org/aphlprograms/infectious/std/ documents/ctgclabguidelinesmeetingreport.pdf.
5. Brooks D. The management of suspected urinary tract infection in general practice. Br J Gen Pract. 1990;40(339):399-401.
6. Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med. 2002;113(Suppl 1):5-13.
7. Johnson RE, Newhall WJ, Papp JR, et al. Screening tests to detect Chlamydia trachomatis and Neisseria gonorrhoeae infections - 2002. MMWR Recomm Rep. 2002;51(No. RR-15):1-38.
8. Centers for Disease Control and Prevention. Epi Info Version 3.5.1. 2008. http://www.cdc.gov/epiinfo/.
9. Diem K, ed. Scientifi c Tables 6th edition. Ardsley, New York: Geigy Pharmaceuticals; 1962.
10. Canterbury District Health Board. Specimen Collection Guidelines - Mid-stream Urine (Female). http://www.cdhb.govt.nz/chlabs/patient/ pdfs/msu_female.pdf.
11. Ostergaard L, Moller, JK, Andersen B, Olesen F. Diagnosis of urogenital Chlamydia trachomatis infection in women based on mailed samples obtained at home: multipractice comparative study. BMJ. 1996;313:1186-1189.
12. Mangin D, Toop L, Chambers S, Ikram R, Harris B. Increased rates of trimethoprim resistance in uncomplicated urinary tract infection: cause for concern? N Z Med J. 2005;118(1225):U1726.